FDG-PET in Early AD Diagnosis

被引：11

作者：

Chew, Jessica ^{[1
]}

Silverman, Daniel H. S. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2013年 / 97卷 / 03期

关键词：

Alzheimer disease; Dementia; Prodromal diagnosis; Fluorodeoxyglucose; PET; Progression; Multimodal imaging; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION WORKGROUPS; MEDIAL TEMPORAL ATROPHY; FRONTOTEMPORAL DEMENTIA; NATIONAL INSTITUTE; PERFUSION SPECT; DISEASE; FLUORODEOXYGLUCOSE; RECOMMENDATIONS;

D O I：

10.1016/j.mcna.2012.12.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

F-18-fludeoxyglucose positron emission tomography (FDG-PET) is an important tool for detecting the early stages of Alzheimer disease (AD). This article discusses the multiple roles FDG-PET plays in helping to diagnose AD, including detecting the disease in the prodromal and early dementia stages, differential diagnosis of dementia, documenting and quantifying cognitive decline, and predicting progression from mild cognitive impairment to AD. In addition, the role of structural magnetic resonance imaging, underutilization of FDG-PET, and a suggested multimodal approach for early AD diagnosis are discussed.

引用

页码：485 / +

页数：11

共 50 条

[1] Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
Rabinovici, G. D.
Rosen, H. J.
Alkalay, A.
Kornak, J.
Furst, A. J.
Agarwal, N.
Mormino, E. C.
O'Neil, J. P.
Janabi, M.
Karydas, A.
Growdon, M. E.
Jang, J. Y.
Huang, E. J.
DeArmond, S. J.
Trojanowski, J. Q.
Grinberg, L. T.
Gorno-Tempini, M. L.
Seeley, W. W.
Miller, B. L.
Jagust, W. J.
[J]. NEUROLOGY, 2011, 77 (23) : 2034 - 2042
[2] Plasma p-tau 181 outperforms FDG-PET in the early diagnosis of biological AD
Quispialaya, Kely
Therriault, Joseph
Aliaga, Antonio
Tissot, Cecile
Servaes, Stijn
Rahmouni, Nesrine
Karikari, Tomas
Benedet, Andrea
Ashton, Nicholas
Macedo, Arthur C.
Firoza, Lussier
Stevenson, Jenna
Wang, Yi-Ting
Fernandez-Arias, Jaime
Hosseini, Seyyed Ali
Nazneen, Tahnia
Jean-Claude, Bertrand
Zimmer, Eduardo R.
Soucy, Jean-Paul
Pascoal, Tharick A.
Gauthier, Serge
Zetterberg, Henrik
Blennow, Kaj
Rosa-Neto, Pedro
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[3] FDG-PET is not useful in early pancreatic cancer diagnosis
Oliver Strobel
Markus W. Büchler
[J]. Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 203 - 205
[4] FDG-PET for Diagnosis of Dementia
Klein, Friederike
[J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (02) : 63 - 63
[5] Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD
Mosconi, L
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (04) : 486 - 510
[6] FDG-PET for the diagnosis of infections.
Moussavian, B
Zhuang, HM
Ponzo, F
Christians, MA
Alavi, A
[J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 43P - 43P
[7] Usefulness of FDG-PET in the Diagnosis of IPMN
Park, K. Y.
Shimoda, M.
Iwasaki, Y.
Kato, M.
Kita, J.
Sawada, T.
Kubota, K.
[J]. PANCREAS, 2009, 38 (08) : 1037 - 1037
[8] PANCREATIC CANCER FDG-PET is not useful in early pancreatic cancer diagnosis
Strobel, Oliver
Buechler, Markus W.
[J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (04) : 203 - 205
[9] FDG-PET for differential diagnosis of pulmonary lesions [FDG-PET in der differenzialdiagnostik pulmonaler raumforderungen]
Willms A.
Willms C.
Schreyer C.
Göller T.
Becker H.P.
Wieler H.
[J]. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2008, 22 (6) : 307 - 313
[10] The utility of FDG-PET in the differential diagnosis of Parkinsonism
Brajkovic, Leposava
Kostic, Vladimir
Sobic-Saranovic, Dragana
Stefanova, Elka
Jecmenica-Lukic, Milica
Jesic, Ana
Stojiljkovic, Milica
Odalovic, Strahinja
Gallivanone, Francesca
Castiglioni, Isabella
Radovic, Branislava
Trajkovic, Goran
Artiko, Vera
[J]. NEUROLOGICAL RESEARCH, 2017, 39 (08) : 675 - 684

← 1 2 3 4 5 →